Zoladex

Links shared publicly online about this topic

Zoladex consumers entitled to treble damages, Court rules

news-medical.net — “The United States Court of Appeals for the First Circuit upheld an earlier District Court ruling yesterday, approving a settlement in the long-running Average Wholesale Price (AWP) pharmaceutical litigation against AstraZeneca Pharmaceuticals ( AZN).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 21, 2009 at 9:30 am By:

prostatecancers News-Medical.Net Health News

Prostate Cancer: Zoladex consumers entitled to treble damages, Court rules: The United States C.. http://bit.ly/07VhuSN

3 years ago...

Acute psychosis in Zoladex - eHealthMe.com

ehealthme.com — “Real world drug outcomes: 2 people have Acute psychosis when using Zoladex. Find out who take the drug, for how long, and how severe is Acute psychosisView full resource at ehealthme.com

  • View Related
  • Share

Most Recently Shared on June 18, 2010 at 9:38 pm By:

Zoladex satisfaction and usage data | Monitoring more than 410 patients | Drug safety information | MediGuard

mediguard.org — “Zoladex satisfaction and usage data | Monitoring more than 410 patients | Drug safety information | MediGuardView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 9:17 pm By:

Drug Alerts : MHRA

mhra.gov.uk — “Drug Alerts : MHRAView full resource at mhra.gov.uk

  • View Related
  • Share

Most Recently Shared on May 12, 2011 at 9:29 am By:

mimsonline MIMS Online Medical Publisher

Class 2 Drug Alert (Action within 48 hours): AstraZeneca UK Ltd - Zoladex 3.6mg Single-dose syringe applicator http://bit.ly/meb7bS

1 year ago...

Another option for premenopausal women with breast cancer | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “A drug that reduces the amount of estrogen in the body can help prevent a recurrence of breast cancer in premenopausal women with the disease. Two years of therapy with the drug, Zoladex, was shown to be just as effective...View full resource at latimesblogs.latimes.com

  • View Related
  • Share

Most Recently Shared on February 24, 2009 at 10:40 pm By:

LATimeshealth LA Times Health News Health News

Another option for premenopausal women with breast cancer: A drug that reduces the amount of estrogen in the bod.. http://tinyurl.com/d5b8nx

3 years ago...

FDA Reviewing Prostate Meds for Diabetes, Heart Risks

healthcentral.com — “Common prostate meds may raise diabetes, heart risks.View full resource at healthcentral.com

  • View Related
  • Share

Most Recently Shared on May 6, 2010 at 5:46 pm By:

Heart_Line Health Line Health Site

#heartdisease FDA Reviewing Prostate Meds for Diabetes, Heart Risks http://w.sns.ly/XrD40

2 years ago...

FDA warns of prostate cancer drug risks - Health - Cancer - msnbc.com

msnbc.msn.com — “* Hormone treatments may raise diabetes, heart risk-FDAView full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 4:41 pm By:

FDA warns of prostate cancer drug risks | Reuters

reuters.com — “WASHINGTON (Reuters) - Hormone treatments for prostate cancer need new warnings about a small increased risk of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday. TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 1:25 am By:

FDA warns of prostate cancer drug risks | Reuters

reuters.com — “WASHINGTON (Reuters) - Hormone treatments for prostate cancer need new warnings about a small increased risk of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday. TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 1:00 am By:

FDA orders new warnings on prostate cancer drugs | Reuters

reuters.com — “WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday. TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 10:27 pm By:

FDA orders new warnings on prostate cancer drugs

health.yahoo.net — “Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 10:07 pm By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

FDA orders new warnings on prostate cancer drugs: Certain hormone treatments for prostate cancer must carry new wa... http://bit.ly/czzEGz

2 years ago...

FDA orders new warnings on prostate cancer drugs | Reuters

reuters.com — “WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday. TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 10:01 pm By:

Reuters_Health Reuters Health Health News

FDA orders new warnings on prostate cancer drugs http://dlvr.it/7JNdQ

2 years ago...

FDA warns of prostate cancer drug risks

health.yahoo.net — “Hormone treatments for prostate cancer need new warnings about a small increased risk of diabetes and heart problems including sudden death, U.S. health officials said on Wednesday.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 10:41 pm By:

HealthSociety Healthy Society Health News

FDA orders new warnings on prostate cancer drugs http://bit.ly/cI5eOW

2 years ago...

FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and Possible Increased Risk of Diabetes and Certain Cardiovascular Diseases - Drugs.com MedNews

drugs.com — “05-03-2010 The U.S. Food and Drug Administration (FDA) is evaluating whether Gonadotropin-Releasing Hormone (GnRH) Agonists may increase the risk of diabetes anView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 4, 2010 at 11:02 pm By:

drugscom Drugs.com Health Site

FDA: Ongoing Safety Review of GnRH Agonists - http://bit.ly/bDyEi7

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related Health Centers

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390